A new slow-release ketamine tablet has shown potential in treating severe depression, offering a convenient and safe at-home alternative to existing treatments. In a randomized-controlled trial, patients on the highest dose of ketamine saw significant reductions in depression symptoms compared to placebo. The tablet form avoids the dissociative effects associated with other ketamine treatments. Further research is needed to confirm these findings and achieve clinical approval.
A new slow-release ketamine tablet has shown potential in treating severe depression, offering a convenient and safe at-home alternative to existing treatments. In a randomized-controlled trial, patients on the highest dose of ketamine saw significant reductions in depression symptoms compared to placebo. The tablet form avoids the dissociative effects associated with other ketamine treatments. Further research is needed to confirm these findings and achieve clinical approval.
Share this Article
Recommended